janagliflozin / Sihuan Pharmaceutical  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
janagliflozin / Sihuan Pharmaceutical
NCT03851432: Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

Unknown status
3
390
RoW
Janagliflozin plus metformin, Placebo plus metformin
Sihuan Pharmaceutical Holdings Group Ltd.
Diabetes Mellitus, Type 2
04/20
12/21
NCT03811548: Janagliflozin Treat T2DM Monotherapy

Unknown status
3
442
RoW
Janagliflozin 25mg, Placebo 50mg, Janagliflozin 50mg, Placebo 25mg, Placebo/Janagliflozin
Sihuan Pharmaceutical Holdings Group Ltd.
Diabetes Type 2
06/20
12/20

Download Options